Yasir B. Al-wakeel - Net Worth and Insider Trading

Yasir B. Al-wakeel Net Worth

The estimated net worth of Yasir B. Al-wakeel is at least $346,102 dollars as of 2024-04-28. Yasir B. Al-wakeel is the CFO of Kronos Bio Inc and owns about 346,102 shares of Kronos Bio Inc (KRON) stock worth over $346,102. Details can be seen in Yasir B. Al-wakeel's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Yasir B. Al-wakeel has not made any transactions after 2023-07-06 and currently still holds the listed stock(s).

Transaction Summary of Yasir B. Al-wakeel

To

Yasir B. Al-wakeel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Yasir B. Al-wakeel owns 4 companies in total, including Kronos Bio Inc (KRON) , Neon Therapeutics Inc (NTGN) , and Merrimack Pharmaceuticals Inc (MACK) among others .

Click here to see the complete history of Yasir B. Al-wakeel’s form 4 insider trades.

Insider Ownership Summary of Yasir B. Al-wakeel

Ticker Comapny Transaction Date Type of Owner
KRON Kronos Bio Inc 2023-07-06 Chief Financial Officer
NTGN Neon Therapeutics Inc 2020-05-06 Chief Financial Officer
MACK Merrimack Pharmaceuticals Inc 2015-08-11 CFO and Head of Corp Dev
MXCT MaxCyte Inc 2021-07-29 director

Yasir B. Al-wakeel Latest Holdings Summary

Yasir B. Al-wakeel currently owns a total of 1 stock. Yasir B. Al-wakeel owns 346,102 shares of Kronos Bio Inc (KRON) as of July 6, 2023, with a value of $346,102.

Latest Holdings of Yasir B. Al-wakeel

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KRON Kronos Bio Inc 2023-07-06 346,102 1.00 346,102

Holding Weightings of Yasir B. Al-wakeel


Yasir B. Al-wakeel Form 4 Trading Tracker

According to the SEC Form 4 filings, Yasir B. Al-wakeel has made a total of 3 transactions in Kronos Bio Inc (KRON) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Kronos Bio Inc is the sale of 9,617 shares on July 6, 2023, which brought Yasir B. Al-wakeel around $16,830.

Insider Trading History of Yasir B. Al-wakeel

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Yasir B. Al-wakeel Trading Performance

GuruFocus tracks the stock performance after each of Yasir B. Al-wakeel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Yasir B. Al-wakeel is 1.24%. GuruFocus also compares Yasir B. Al-wakeel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Yasir B. Al-wakeel within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Yasir B. Al-wakeel's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Yasir B. Al-wakeel

Average Return

-47.99%

Average return per transaction

Outperforming Transactions

0%

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -11.66 1.24 -30.28 -47.99 -70.01 -68.47
Relative Return to S&P 500(%) -14.43 -7.56 -48.51 -75.21 -71.35 -75.93

Yasir B. Al-wakeel Ownership Network

Ownership Network List of Yasir B. Al-wakeel

No Data

Ownership Network Relation of Yasir B. Al-wakeel


Yasir B. Al-wakeel Owned Company Details

What does Kronos Bio Inc do?

Who are the key executives at Kronos Bio Inc?

Yasir B. Al-wakeel is the Chief Financial Officer of Kronos Bio Inc. Other key executives at Kronos Bio Inc include COO & General Counsel Barbara Kosacz , Chief Scientific Officer Christopher Dinsmore , and Chief Medical Officer & VP Jorge Dimartino .

Kronos Bio Inc (KRON) Insider Trades Summary

Over the past 18 months, Yasir B. Al-wakeel made 2 insider transaction in Kronos Bio Inc (KRON) with a net sale of 18,643. Other recent insider transactions involving Kronos Bio Inc (KRON) include a net sale of 69,004 shares made by Jorge Dimartino , a net sale of 39,461 shares made by Christopher Dinsmore , and a net purchase of 1,731,056 shares made by Norbert W Bischofberger .

In summary, during the past 3 months, insiders sold 31,509 shares of Kronos Bio Inc (KRON) in total and bought 0 shares, with a net sale of 31,509 shares. During the past 18 months, 169,293 shares of Kronos Bio Inc (KRON) were sold and 1,731,056 shares were bought by its insiders, resulting in a net purchase of 1,561,763 shares.

Kronos Bio Inc (KRON)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kronos Bio Inc Insider Transactions

No Available Data

Yasir B. Al-wakeel Mailing Address

Above is the net worth, insider trading, and ownership report for Yasir B. Al-wakeel. You might contact Yasir B. Al-wakeel via mailing address: Merrimack Pharmaceuticals, Inc., One Kendall Square, Suite B7201, Cambridge Ma 02139.

Discussions on Yasir B. Al-wakeel

No discussions yet.